Salix Pharma beats by $0.03, misses on revenues

Salix Pharmaceuticals (SLXP): FQ3 EPS of $0.89 beats by $0.03.

Revenue of $238.2M (+29% Y/Y) misses by $1.5M.

Shares +3.2%. (PR)

From other sites
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs